Rampart IC Expands its International Distribution Network

Share Article

Rampart IC, a Birmingham-based medical device company specializing in radiation shielding and orthopedic protection, has signed five distribution agreements that expand their distribution throughout the Middle East, Asia, Europe and North America.

“Rampart’s global mission is to protect as many interventional teams as possible,” said Tom Livingston, Rampart IC CEO. “This year we have expanded our partnerships with several companies, all renowned in their home countries for sourcing and providing the best medical equipment to practitioners.”

Rampart IC, a Birmingham-based medical device company specializing in radiation shielding and orthopedic protection, has signed five distribution agreements that expand their distribution throughout the Middle East, Asia, Europe and North America.

Medpoint Technologies Ltd, headquartered in Israel, will distribute Rampart IC throughout Israel and Palestine. PrismTech, headquartered in Hong Kong, will handle distribution in Hong Kong. Heart Beat Medical Supplies, headquartered in Dubai, will distribute throughout the United Arab Emirates, Qatar, Kuwait, Oman and Egypt. Oryx Medical, headquartered in Toronto, will distribute within Canada.

Rampart IC has existing distribution agreements in place with med tech distributors serving medical facilities throughout Europe, Australia and New Zealand, and Japan. Rampart manages direct sales within the United States.

The Rampart M1128 is a device developed for interventional cardiologists (ICs), but has found its way into several interventional specialties. Interventionalists and their teams spend extended time in catheterization labs and, therefore, rank as the occupation with the highest level of radiation exposure in the world1. ICs often face debilitating injuries resulting from 20-30 pound lead aprons traditionally worn to reduce radiation exposure2, with nearly half reporting some form of orthopedic injury3.

The Rampart IC system is in use with American healthcare systems including Ascension, Sutter Health and Northwell. The technology has been adopted by prestigious medical institutions like Emory University Healthcare System and UAB Medicine.

“Rampart’s global mission is to protect as many interventional teams as possible,” said Tom Livingston, Rampart IC Chief Executive Officer. “This year we have expanded our partnerships with several companies, all renowned in their home countries for sourcing and providing the best medical equipment to practitioners. We are proud to come alongside them and make Rampart IC more widely available, facilitating quality care for patients while protecting the health and safety of interventionalists.”

Statements from the new members of Rampart IC’s distribution network:

"The Rampart system will change X-ray protection in interventional labs and create a new era of protection to the lab team,” said Ruben Cohen, CEO with Medpoint Technologies Ltd. “It is an absolute game changer in the interventional field"

"We at PrismTech are excited to offer our interventional customers in Hong Kong this game changing and value-added solution,” said Raymon Chan, Director, Strategic Business of PrismTech. “We believe this technology will significantly improve the way lab teams are protected from occupational injury.”

“Heart Beat Medical Supplies LLC continues to represent innovation, which provides significant value to healthcare providers,” said Eyad Sadek and Salman Derbieh, Radiology Department Team. “We believe Rampart IC is the future for cath lab safety and is essential in securing the comfort, safety, health and improved quality of life of our healthcare workers."

“Oryx Medical is excited to bring Rampart to Canada and help better protect Canadian interventionalists,” said Trevor Doran, Managing Director of Oryx. We are passionate to deliver innovation to our healthcare partners and Rampart is delivering game-changing protection around the world. We’re proud to represent a technology that will provide greater protection today and reduce long-term health risks to healthcare professionals simply doing their jobs.”

“Because the safety, comfort and well-being of medical and paramedical teams are at the heart of our concerns, we at SOLYCARE are excited to offer our interventional customers in FRANCE this game changing solution,” said Olivier Mereau, General Manage with SOLYCARE. “We believe Rampart IC will change the way cath lab teams are protected from occupational injury in this strategic healthcare segment.”

Rampart IC is a Birmingham, Alabama-based medical device company specializing in radiation shielding. Praised by the leading interventional cardiologists in the field, Rampart’s technologies have been adopted by prestigious health systems around the globe, including Ascension, Sutter Health and Northwell, and by renowned institutions like Emory University Healthcare System and UAB Medicine.
Visit us at rampartic.com.

1. Zakeri F, Hirobe T, Akbari K. Biological effects of the low–dose radiation exposure on interventional cardiologist. International atomic energy agency: Occ Med ( Lond) 2010;60(6): 464-9

2. Orme NM, Rihal CS, Gulati R, et al. Occupational health hazards of working in the interventional laboratory: a multisite case control study of physicians and allied staff. J Am Coll Cardiol 2015; 65: 820-6.

3. Klein LW, Tra Y, Garratt KN, et al. Society for Cardiovascular Angiography and Interventions. Occupational health hazards of interventional cardiologists in the current decade: Results of the 2014 SCAI membership survey. Catheter Cardiovasc Interv. 2015 Nov; 86(5):913-24.

-30-

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dana McGough